Elena Marquez sold $401k of ATEX
Chief Financial Officer at Anterix Inc.. 4,981 shares at an average of $80.43, traded Oct 9, 2026, filed Oct 13, 2026.
Score components
This filing reached EDGAR on Oct 13, 2026, so its score and components open to free visitors on Oct 20, 2026. The trade itself, the rows in the filing and the price context are public now.
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002090789-26-000016, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -3,254 | $80.16 | $261k | 13,104 | 20 h ago |
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -400 | $81.80 | $33k | 12,704 | 20 h ago |
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -100 | $82.50 | $8,250 | 12,604 | 20 h ago |
| Oct 9, 2026 | MOption exercise Common Stock10b5-1 | +1,227 | $40.00 | $49k | 13,831 | 20 h ago |
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -1,017 | $80.22 | $82k | 12,814 | 20 h ago |
| Oct 9, 2026 | SOpen-market sale Common Stock10b5-1 | -210 | $81.90 | $17k | 12,604 | 20 h ago |
| Oct 9, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,227 | $0.00 | $0 | 1,227 | 20 h ago |
Related signals
Other insiders at Anterix Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | Anterix Inc. | Scott A. Lang President and CEO | $1.2M 15,000 shares | -36% | |
| 75Notable | Anterix Inc. | Scott A. Lang President and CEO | $1.2M 15,000 shares | -36% | |
| 42Moderate | Anterix Inc. | Leslie B Daniels director | $210k 2,500 shares | -5% | |
| 56Moderate | Anterix Inc. | Heather Martin Chief Marketing Officer | $679k 8,064 shares | -23% | |
| 40Moderate | Anterix Inc. | Gena L Ashe Chief Legal Officer & Corp Sec | $372k 4,357 shares | -46% | |
| 58Moderate | Anterix Inc. | Leslie B Daniels director | $880k 10,100 shares | -18% | |
| 55Moderate | Anterix Inc. | Gena L Ashe Chief Legal Officer & Corp Sec | $372k 4,357 shares | -46% | |
| 50Moderate | Anterix Inc. | Christopher Guttman-McCabe Chief Reg & Comm Officer | $2.2M 23,439 shares | -34% | |
| 60Notable | Anterix Inc. | Thomas R. Kuhn director, other | $1.0M 11,654 shares | -60% | |
| 55Moderate | Anterix Inc. | William Heard director | $4.2M 46,400 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.